Hazel Hunt
Chief Tech/Sci/R&D Officer at CORCEPT THERAPEUTICS INCORPORATED
Net worth: 2 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joseph Belanoff | M | 66 | 26 years | |
| Gary Robb | M | 61 | 13 years | |
| George Baker | M | 81 | 25 years | |
| James Wilson | M | 80 | 25 years | |
| David Mahoney | M | 69 | 20 years | |
| Atabak Mokari | M | 47 | 3 years | |
| Daniel Swisher | M | 61 | 9 years | |
| Amy E. Flood | F | - | 3 years | |
| Gregg Alton | M | 58 | 4 years | |
| Sean Maduck | M | 47 | 12 years | |
| Joseph Lyon | M | 46 | 12 years | |
| Kimberly Park | F | 60 | 5 years | |
| Gillian Cannon | M | 60 | 4 years | |
| Joshua Murray | M | 40 | 3 years | |
| Monica Tellado | F | 51 | 1 years | |
| William Guyer | M | 56 | 3 years | |
| Jerry Pan | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert L. Roe | M | 83 | 12 years | |
| Caroline Loewy | F | 58 | 3 years | |
| Renée Galá | F | 52 | 3 years | |
| Anthony David Baxter | M | 63 |
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | 4 years |
| Christopher Gregory Newton | M | 68 |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | 5 years |
| Harry Finch | M | - |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | - |
| John Montana | M | - |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | - |
| Daniel Bradbury | M | 62 | 7 years | |
| Christopher Moyses | M | - |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | - |
| Joseph Turner | M | 72 | 4 years | |
| Patrick Enright | M | 62 | 9 years | |
| John Johnson | M | 66 | - | |
| David Penake | M | - | - | |
| Thaddeus S. Block | M | - | - | |
| Susan P. Rinne | F | 72 | 11 years | |
| Steven Lo | M | 57 | 5 years | |
| Sue Snape | M | - |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | - |
| Anne M. LeDoux | F | 76 | 11 years | |
| Christopher S. James | M | - | 4 years | |
| Hugo Slootweg | M | 53 |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | 9 years |
| Robert Fishman | M | 62 | 4 years | |
| Colin Graham Knox | M | 53 |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | - |
| Ian Fletcher Kent | M | - |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | - |
| Richard S. Kollender | M | 54 | - | |
| Andreas Grauer | M | 63 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 33 | 78.57% |
| United Kingdom | 9 | 21.43% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hazel Hunt
- Personal Network
